Clinical trial

HIV Pre-exposure Prophylaxis Implementation Study in South Korea

NCT04583267

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-08-28

PhaseNA

Study timeline

Study start (actual)2018-08-28Date precision: day

Registry last updated2020-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administrationDRUG

Sponsors & collaborators

Yonsei Universitylead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04583267 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.